David Layne
Family Medicine · Belmont, NCNPI 1720045958
Payments from drug & device makers
Across 314 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$803
- Johnson & Johnson$770
- AbbVie$679
- Amgen$663
- Pfizer$566
- Lilly USA, LLC$472
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,338100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $803 |
| Johnson & Johnson | 33 | $770 |
| AbbVie(2 entities) | 49 | $679 |
| Amgen | 26 | $663 |
| Pfizer | 31 | $566 |
| Lilly USA, LLC | 22 | $472 |
| Novo Nordisk | 16 | $273 |
| E.r. Squibb & Sons, L.L.C. | 9 | $180 |
| Teva Pharmaceuticals USA, Inc. | 12 | $173 |
| Idorsia Pharmaceuticals US Inc | 9 | $168 |
| Eisai Inc. | 6 | $149 |
| Kowa Pharmaceuticals America, Inc. | 8 | $135 |
| Bayer | 8 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $123 |
| Amarin Pharma, Inc. | 2 | $108 |
| Exact Sciences | 1 | $102 |
| Biohaven Pharmaceuticals, Inc. | 5 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $82 |
| Boehringer Ingelheim | 5 | $79 |
| Antares Pharma, Inc. | 4 | $70 |
| Ironshore Pharmaceuticals Inc. | 5 | $68 |
| Tolmar, Inc. | 3 | $67 |
| GSK | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 1 | $47 |
| Abbott | 2 | $43 |
| Neos Therapeutics, LP | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Boston Scientific | 1 | $24 |
| Abiomed | 1 | $22 |
| Nevro Corp. | 1 | $20 |
| Merck | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,357 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $74,928 |
| EliquisApixaban | 81 | $59,075 |
| OzempicSemaglutide | 30 | $27,459 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $9,373 |
| GlyxambiEmpagliflozin/Linagliptin | 13 | $7,974 |
| Repatha SureclickEvolocumab | 13 | $7,184 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,445 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 211 | $3,329 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $3,037 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 74 | $2,725 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,543 |
| Testosterone Cypionate | 23 | $1,318 |
| Tamsulosin Hcl | 66 | $1,239 |
| Gabapentin | 106 | $1,167 |
| Atorvastatin Calcium | 161 | $1,125 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $566 | $59,07581 claims |
| Novo NordiskOzempic | $273 | $27,45930 claims |
| GSKBreo Ellipta, Anoro Ellipta | $57 | $14,81930 claims |
| Boehringer IngelheimGlyxambi | $79 | $7,97413 claims |
| AbbVieArmour Thyroid | $679 | $54214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Belmont
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.